RecruitingPhase 3NCT07128199A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor ResectionSponsor: Taiho Oncology, Inc.Margate, FL · Orange City, FL · +28 more sites
RecruitingPhase 1 / Phase 2NCT05785741A Study of DB-1310 in Advanced/Metastatic Solid TumorsSponsor: DualityBio Inc.Coral Gables, FL · Margate, FL · Orlando, FL · +12 more sites
RecruitingPhase 1 / Phase 2NCT05914116A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsSponsor: DualityBio Inc.Celebration, FL · Margate, FL · Orlando, FL · +25 more sites